Photo courtesy of BiotecFor the first time last week, the National Centre for Genetic Engineering and Biotechnology (Biotec) unveiled three coronavirus vaccines that are currently in development. It creates antibodies to catch the spike protein and block its entry into host cells," said Surapong Koonpaew, who works in the virology and cell technology research team. A vaccine with an adenovirus base can carry the long spike protein but the one with an influenza base can keep only the tiny receptor-binding domain of the spike protein due to a constraint. We need to talk with the Food and Drug Administration to speed up the process because only the spike protein has changed," she said. Scientists should improve machine learning to classify and annotate large amounts of genomic data and model human immune responses to predict pathogens and mutations.

Source: Bangkok Post August 16, 2021 23:37 UTC